Curran Simpson
CIK: 0001346164
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENXBIO Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 1, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct6.8K shares at avg. $13.09$89K - Jun 30, 2026RGNX
REGENXBIO Inc.
Award(A)Direct1.5K shares at avg. $10.18$15K - Jan 6, 2026RGNX
REGENXBIO Inc.
Award(A)Direct144.9K shares- - Jan 2, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct18.6K shares at avg. $14.40$267K - Dec 31, 2025RGNX
REGENXBIO Inc.
Award(A)Direct951 shares at avg. $7.00$7K - Oct 9, 2025RGNX
REGENXBIO Inc.
Sale(S)Direct20.8K shares at avg. $12.62$263K - Sep 29, 2025RGNX
REGENXBIO Inc.
Sale(S)Direct7.6K shares at avg. $10.03$76K - Sep 10, 2025RGNX
REGENXBIO Inc.
Sale(S)Direct7.7K shares at avg. $10.02$77K - Jul 1, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct4.7K shares at avg. $8.23$39K - Jan 2, 2025RGNX
REGENXBIO Inc.
Award(A)DirectStock Options (Right to buy)
478.6K shares- - Jan 2, 2025RGNX
REGENXBIO Inc.
Award(A)Direct98.9K shares- - Jan 2, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct11.9K shares at avg. $7.73$92K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 6,818 | $13.09 | $89,248 | Direct |
| Jun 30, 2026 | RGNX REGENXBIO Inc. | Award(A) | 1,453 | $10.18 | $14,792 | Direct |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | Award(A) | 144,864 | - | $0 | Direct |
| Jan 2, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 18,559 | $14.40 | $267,250 | Direct |
| Dec 31, 2025 | RGNX REGENXBIO Inc. | Award(A) | 951 | $7.00 | $6,653 | Direct |
| Oct 9, 2025 | RGNX REGENXBIO Inc. | Sale(S) | 20,811 | $12.62 | $262,635 | Direct |
| Sep 29, 2025 | RGNX REGENXBIO Inc. | Sale(S) | 7,624 | $10.03 | $76,469 | Direct |
| Sep 10, 2025 | RGNX REGENXBIO Inc. | Sale(S) | 7,734 | $10.02 | $77,495 | Direct |
| Jul 1, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 4,701 | $8.23 | $38,689 | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Award(A) Stock Options (Right to buy) | 478,606 | - | - | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Award(A) | 98,912 | - | $0 | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 11,917 | $7.73 | $92,118 | Direct |
1-12 of 12 transactions
About Simpson Curran
Simpson Curran (SEC CIK 0001346164) files insider reports with the SEC as Chief Executive Officer of REGENXBIO Inc. (RGNX).
Signal8 holds 9 ownership filings by Simpson Curran, all Form 4s, filed between Jan 6, 2025 and Jul 6, 2026. Those filings report 12 transactions, from Jan 2, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Simpson Curran's filings is in ROCKVILLE, MD.
Recent filings by Simpson Curran
- Jul 1, 2026: Tax withholding of RGNX shares (Form 4, code F).
- Jun 30, 2026: Grant or award of RGNX shares (Form 4, code A).
- Jan 6, 2026: Grant or award of RGNX shares (Form 4, code A).
- Jan 2, 2026: Tax withholding of RGNX shares (Form 4, code F).
- Dec 31, 2025: Grant or award of RGNX shares (Form 4, code A).
Other insiders filing for REGENXBIO Inc. (RGNX)
- Malzahn Craig, Chief Technology Officer
- Christmas Patrick J., Chief Strategy & Legal Officer
- PAKOLA STEVE, Chief Medical Officer
- Chan Mitchell, Chief Financial Officer
- Ciongoli Gregory Austin, Director
- Tasse Daniel, Director